TLDRocket
Sign in

rentosertib

Technology Covered in 2 stories + Follow

This profile is built automatically from TLDRocket coverage.

Latest developments

Timeline

Month Quarter Year

Q3 2026

Insilico Medicine reported early phase 2a trial results for its AI-designed fibrosis drug showing reductions in predicted biological age across multiple proteomic aging clocks Benchmark result

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.